Stay updated on Risankizumab vs Secukinumab in Psoriasis Clinical Trial

Sign up to get notified when there's something new on the Risankizumab vs Secukinumab in Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Risankizumab vs Secukinumab in Psoriasis Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision: v3.5.4 was added and Revision: v3.5.3 was removed, indicating an updated release tag for the page's documentation assets.
    Difference
    0.0%
    Check dated 2026-05-15T06:58:52.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision/version indicator on the study page has been updated from v3.5.2 to v3.5.3, reflecting a site maintenance or release update rather than a change to the clinical study content.
    Difference
    0.0%
    Check dated 2026-04-24T05:43:17.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Version updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:12:43.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Site revision indicator updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-18T21:07:51.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added. Revision: v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-11T20:08:00.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    Site banner updated to Revision: v3.4.2, and the prior government funding lapse notice has been removed.
    Difference
    0.3%
    Check dated 2026-02-11T10:57:57.000Z thumbnail image

Stay in the know with updates to Risankizumab vs Secukinumab in Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Risankizumab vs Secukinumab in Psoriasis Clinical Trial page.